Acetylsalicylic acid as an adjuvant therapy for schizophrenia

Overview of attention for article published in Trials, October 2006

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial.

Article in Psychopharmacology Bulletin (April 2024)

Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders

Article in Journal of Personalized Medicine (September 2023)

Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders.

Article in Behavioural Pharmacology (December 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.